Mechanisms of sorafenib resistance in hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mechanisms of sorafenib resistance in hepatocellular carcinoma

Published:2024-10 Issue:8 Volume:48 Page:102434
ISSN:2210-7401
Container-title:Clinics and Research in Hepatology and Gastroenterology
language:en
Short-container-title:Clinics and Research in Hepatology and Gastroenterology

Author:

Liang Yuanjing

Publisher

Elsevier BV

Reference53 articles.

1. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy;Singal;Nat Rev Clin Oncol,2023

2. B. thetaiotaomicron-derived acetic acid modulate immune microenvironment and tumor growth in hepatocellular carcinoma;Ma;Gut Microbes,2024

3. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update;Reig;J Hepatol,2022

4. Evolving therapeutic landscape of advanced hepatocellular carcinoma;Yang;Nat Rev Gastroenterol Hepatol,2023

5. Novel nanoparticle CS-C60-Fe3O4 magnetically induces tissue-specific aggregation and enhances thermal ablation of hepatocellular carcinoma;Sun;Cancer Nanotechnol,2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP